Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer.
about
Association of colorectal cancer with pathogenic Escherichia coli: Focus on mechanisms using optical imagingDiet, Microbiota, Obesity, and NAFLD: A Dangerous QuartetGut microbiota imbalance and colorectal cancerThe gut microbiota and host health: a new clinical frontierBacterial Genotoxins: Merging the DNA Damage Response into Infection BiologyFusobacterium and Enterobacteriaceae: important players for CRC?The therapeutic value of targeting inflammation in gastrointestinal cancersCurrent Hypothesis for the Relationship between Dietary Rice Bran Intake, the Intestinal Microbiota and Colorectal Cancer PreventionMicrobiota, Inflammation and Colorectal Cancer.The detection of the methylated Wif-1 gene is more accurate than a fecal occult blood test for colorectal cancer screening.Escherichia coli-host macrophage interactions in the pathogenesis of inflammatory bowel disease.Escherichia coli in chronic inflammatory bowel diseases: An update on adherent invasive Escherichia coli pathogenicityMaternally acquired genotoxic Escherichia coli alters offspring's intestinal homeostasis.Microbial genomic analysis reveals the essential role of inflammation in bacteria-induced colorectal cancer.Microbial imbalance and intestinal pathologies: connections and contributionsFrom promotion to management: the wide impact of bacteria on cancer and its treatmentPathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challengesRecent advancement in understanding colitis-associated tumorigenesis.Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease.Pathogenesis of Crohn's disease: Bug or no bug.Quantitative profiling of colorectal cancer-associated bacteria reveals associations between fusobacterium spp., enterotoxigenic Bacteroides fragilis (ETBF) and clinicopathological features of colorectal cancer.Systematic review: bile acids and intestinal inflammation-luminal aggressors or regulators of mucosal defence?A Preliminary Study Examining the Binding Capacity of Akkermansia muciniphila and Desulfovibrio spp., to Colonic Mucin in Health and Ulcerative Colitis.Early settlers: which E. coli strains do you not want at birth?Commensal bacterial internalization by epithelial cells: An alternative portal for gut leakinessPresence of Porphyromonas gingivalis in esophagus and its association with the clinicopathological characteristics and survival in patients with esophageal cancerRevealing potential molecular targets bridging colitis and colorectal cancer based on multidimensional integration strategy.Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin DIncreased Enterococcus faecalis infection is associated with clinically active Crohn disease.Association of oncogenic bacteria with colorectal cancer in South ChinaCancer associated faecal microbial markers in colorectal cancer detection.Role of Proteus mirabilis MR/P fimbriae and flagella in adhesion, cytotoxicity and genotoxicity induction in T24 and Vero cells.Clonal evolution of colorectal cancer in IBD.E. coli Sepsis: Red Flag for Colon Carcinoma-A Case Report and Review of the Literature.Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon Carcinogenesis.Alteration of Esophageal Microbiome by Antibiotic Treatment Does Not Affect Incidence of Rat Esophageal Adenocarcinoma.Fusobacterium nucleatum in colorectal carcinoma tissue and patient prognosis.Escherichia coli from Crohn's disease patient displays virulence features of enteroinvasive (EIEC), enterohemorragic (EHEC), and enteroaggregative (EAEC) pathotypes.A prospective analysis of mucosal microbiome-metabonome interactions in colorectal cancer using a combined MAS 1HNMR and metataxonomic strategySmall-molecule inhibitors prevent the genotoxic and protumoural effects induced by colibactin-producing bacteria.
P2860
Q24658471-B65CEA0C-6D7A-4237-87C0-36010CD7C4C9Q26752614-2CDB3B03-B6FD-4469-82BD-AA560F3D4848Q26774708-85AF5246-9935-47BA-8D5E-43498BA2B9C8Q26785649-FD475FAA-D70D-4057-A929-45A486E24DF3Q26798188-D2C723B4-CA6A-4AF0-923B-0358FDB45099Q26865094-D604B310-8003-4070-824D-BE07C1CC931FQ27024203-9F9ACA28-00D7-426B-B3D2-270AAAB4F9BDQ28080177-95BE46DD-8EC6-4DB6-A28B-4A115A432E8CQ33839116-78083C1E-5610-42A9-86D5-74994358F7E0Q33904046-73F9F791-7DC1-4A1B-8BD5-CC5EACC99FF9Q33958858-4B55B93C-4D7E-4A5B-AD0C-4B76303632D3Q34048001-BFDB4466-C35E-4F3B-932C-E0A89E2B78C5Q34129345-AF065A65-3836-400D-B480-7804089E88AEQ34137586-3F6CC96B-E355-4EE3-BC7E-9F9569050958Q34241115-AB9C9A78-5F68-4C2E-A2C0-B32B7033DF8FQ34263890-67813E81-D8EA-4B79-AA8F-B17E621B7EA0Q34297628-90BB5B86-2B94-4247-9470-6A571B9E5E11Q34390271-F6461C85-1CFA-436F-A378-6C5D92AB8841Q35040827-92DCD7BA-5BE9-42D4-862A-CF3D36D261B5Q35075535-430DDB8F-1CAF-471B-A5C9-F741BEEA515DQ35159162-2D9921D3-E4C7-45C9-863E-53218A292920Q35724871-F6E48718-E4C1-400E-8CB8-7C76BE3993AEQ35817095-073A68A5-B08C-41AF-AD7C-BEE910C02F8BQ36049274-AD9A2BA2-713F-4D16-BA3A-0DA8576FEDF2Q36072641-B76FF92E-BC24-4EE8-920D-2FEDF789CB03Q36475989-367BC804-926E-4A11-B7B5-C7A1F44E223AQ36545820-023EE8F5-24B8-4729-A7B1-94302C662FF8Q36973431-CA4019F8-5A03-47B3-8029-A79AAD2D2DA4Q37605952-11541F09-738A-46C9-8284-5D3DF4B8FC7FQ37697073-2FFBEEA5-AEDA-4FD2-B586-6F9E04A8D72CQ38638269-AB5FEC9D-58E0-4CC0-82C2-570E7A55AED3Q38905304-7526A1BC-6579-4A82-959F-11102B41D02FQ38973304-48BC2376-5F8D-41A6-AF99-F70C58223040Q39427299-9C1B7E80-0914-4D26-AD8D-D88A5974E8DDQ40460894-68401A55-A844-4D89-8995-30DFB6687587Q40537150-5735BAC9-B682-41C2-8494-050593F32D04Q40603067-C3D1671A-EF63-4737-A697-BE791A79A1CDQ41476186-AD87D5E6-EE08-4A43-9A7C-C2B0531F3587Q41484399-63101EDF-73E8-4DE8-9F6C-16344F0BDDF0Q41583397-F227244E-F1CB-407A-B61D-5744824A7856
P2860
Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Colonic mucosa-associated diff ...... owel disease and colon cancer.
@ast
Colonic mucosa-associated diff ...... owel disease and colon cancer.
@en
Colonic mucosa-associated diff ...... owel disease and colon cancer.
@nl
type
label
Colonic mucosa-associated diff ...... owel disease and colon cancer.
@ast
Colonic mucosa-associated diff ...... owel disease and colon cancer.
@en
Colonic mucosa-associated diff ...... owel disease and colon cancer.
@nl
prefLabel
Colonic mucosa-associated diff ...... owel disease and colon cancer.
@ast
Colonic mucosa-associated diff ...... owel disease and colon cancer.
@en
Colonic mucosa-associated diff ...... owel disease and colon cancer.
@nl
P2093
P2860
P50
P1433
P1476
Colonic mucosa-associated diff ...... bowel disease and colon cancer
@en
P2093
Abdullah Alswied
Carol L Roberts
Caroline Codling
Jonathan M Rhodes
Maelle Prorok-Hamon
Melissa K Friswell
Paul K Flanagan
Paul Knight
P2860
P304
P356
10.1136/GUTJNL-2013-304739
P407
P577
2013-07-11T00:00:00Z